In India, where many diabetic patients are elderly and managing multiple conditions, this makes gliptins a very practical choice. Mohammad Junaid Rain, MBBS 2nd Year Key advantages of DPP-4 inhibitors: No hypoglycemia risk No weight gain weight neutral Once daily tablet simple to take Safe for elderly patients Can be used with kidney disease (dose adjustment needed) Limitations: Moderate glucose lowering not the strongest drug More expensive than sulfonylureas Rare risk of joint pain and pancreatitis Part 2 Sulfonylureas Common names: Glimepiride, Glipizide, Gliclazide, Glibenclamide Indian brands: Amaryl, Glynase, Diamicron, Daonil Sulfonylureas are the oldest class of oral diabetes drugs used since the 1950s
Having sufficient levels of Vitamin D has been shown to reduce the chance of us becoming ill, and/or improving the speed of our recovery
Particularly for both L-carnitine and acetyl-L-carnitine, they have been shown to prevent cell death in animal models of brain injury among the adult, pediatric, and neonatal populations
GLP-1 RAs exerted neuroprotective effects by inhibiting glutamate accumulation to prevent excitotoxicity and neural apoptosis [39], which possibly explains the protective effects of the GLP1R gene on background DR and severe nonproliferative DR, but not proliferative DR
